The ROE as of November 2024 (TTM) for Forte Biosciences, Inc. (FBRX) is -151.43%

According to Forte Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -151.43%. This represents a change of 194.24% compared to the average of -51.46% of the last 4 quarters.

Forte Biosciences, Inc. (FBRX) Historical ROE (quarterly & annually)

How has FBRX ROE performed in the past?

The mean historical ROE of Forte Biosciences, Inc. over the last ten years is -100.17%. The current -151.43% ROE has changed 51.18% with respect to the historical average. Over the past ten years (40 quarters), FBRX's ROE was at its highest in in the March 2017 quarter at 601.66%. The ROE was at its lowest in in the December 2019 quarter at -184.18%.

Forte Biosciences, Inc. (FBRX) ROE by Quarter and Year

Discovering the peaks and valleys of Forte Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Forte Biosciences, Inc. (FBRX) Average ROE

How has FBRX ROE performed in the past?

The current ROE of Forte Biosciences, Inc. (FBRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Forte Biosciences, Inc. (FBRX) ROE vs. Peers

How is FBRX’s ROE compared to its peers?

Forte Biosciences, Inc.’s ROE is greater than Indaptus Therapeutics, Inc. (-177.27%), greater than Rezolute, Inc. (-69.83%), greater than Tempest Therapeutics, Inc. (-187.44%), less than Comera Life Sciences Holdings, Inc. (67.46%), greater than ABVC BioPharma, Inc. (-98.40%), greater than Pasithea Therapeutics Corp. (-15595.10%), less than Better Therapeutics, Inc. (129.80%), less than ZIVO Bioscience, Inc. (618.61%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than Erasca, Inc. (-42.26%), greater than Applied Molecular Transport Inc. (-131.59%), greater than Werewolf Therapeutics, Inc. (-58.83%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than Celcuity Inc. (-62.66%), greater than C4 Therapeutics, Inc. (-42.45%),

Build a custom stock screener for Forte Biosciences, Inc. (FBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Forte Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Forte Biosciences, Inc. (FBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Forte Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.